Argentina Non-viral Gene Delivery Technologies Market Size & Outlook
Related Markets
Argentina non-viral gene delivery technologies market highlights
- The Argentina non-viral gene delivery technologies market generated a revenue of USD 58.0 million in 2024 and is expected to reach USD 106.3 million by 2030.
- The Argentina market is expected to grow at a CAGR of 11.3% from 2025 to 2030.
- In terms of segment, chemical was the largest revenue generating mode in 2024.
- Chemical is the most lucrative mode segment registering the fastest growth during the forecast period.
Non-viral gene delivery technologies market data book summary
| Market revenue in 2024 | USD 58.0 million |
| Market revenue in 2030 | USD 106.3 million |
| Growth rate | 11.3% (CAGR from 2025 to 2030) |
| Largest segment | Chemical |
| Fastest growing segment | Chemical |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemical, Physical |
Other key industry trends
- In terms of revenue, Argentina accounted for 1.6% of the global non-viral gene delivery technologies market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil non-viral gene delivery technologies market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 183.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-Viral Gene Delivery Technologies Market Scope
Non-Viral Gene Delivery Technologies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Innovative Cell Technologies | View profile | 1-10 | San Diego, California, United States, North America | http://www.accutase.com/ |
| SIRION BIOTECH | View profile | 11-50 | Martinsried, Bayern, Germany, Europe | http://www.sirion-biotech.com |
| Altogen Biosystem | View profile | 51-100 | Las Vegas, Nevada, United States, North America | https://www.altogen.com |
| GenScript | View profile | - | - | - |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Argentina non-viral gene delivery technologies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-viral gene delivery technologies market will help companies and investors design strategic landscapes.
Chemical was the largest segment with a revenue share of 64.48% in 2024. Horizon Databook has segmented the Argentina non-viral gene delivery technologies market based on chemical, physical covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Argentina non-viral gene delivery technologies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina non-viral gene delivery technologies market databook
-
Our clientele includes a mix of non-viral gene delivery technologies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina non-viral gene delivery technologies market , including forecasts for subscribers. This country databook contains high-level insights into Argentina non-viral gene delivery technologies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina non-viral gene delivery technologies market size, by mode, 2018-2030 (US$M)
Argentina Non-Viral Gene Delivery Technologies Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
